APA (7th ed.) Citation

Luo, B., Sun, Y., Zhan, Q., Luo, Y., Chen, Y., Fu, T., . . . Ke, Z. (2024). Combining TIGIT blockade with IL‐15 stimulation is a promising immunotherapy strategy for lung adenocarcinoma. Clinical & Translational Medicine, 14(1), 1. https://doi.org/10.1002/ctm2.1553

Chicago Style (17th ed.) Citation

Luo, Baohong, et al. "Combining TIGIT Blockade with IL‐15 Stimulation Is a Promising Immunotherapy Strategy for Lung Adenocarcinoma." Clinical & Translational Medicine 14, no. 1 (2024): 1. https://doi.org/10.1002/ctm2.1553.

MLA (9th ed.) Citation

Luo, Baohong, et al. "Combining TIGIT Blockade with IL‐15 Stimulation Is a Promising Immunotherapy Strategy for Lung Adenocarcinoma." Clinical & Translational Medicine, vol. 14, no. 1, 2024, p. 1, https://doi.org/10.1002/ctm2.1553.